NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hypercholesterolemia



Effect of Estrogen and Simvastatin on Low-Density Lipoprotein Subclasses in Hypercholesterolemic Post-menopausal Women



September 28th, 1998

According to the authors' abstract of an article published in Obstetrics and Gynecology, "Objective: To identify the effects of estrogen and simvastatin, individually and in combination, on the levels of low-density lipoprotein (LDL) subclasses in post-menopausal women with type IIa hypercholesterolemia. Methods: Fifty-five post-menopausal women with type IIa hypercholesterolemia were assigned randomly to 0.625 mg of conjugated equine estrogen (n=20), 5 mg of simvastatin (n=18), or both (n=17) daily for 3 months. Cholesterol, triglyceride, and apolipoprotein B levels in the plasma and in the LDL1 (density 1.019-1.045 g/mL) and LDL2 (density 1.045-1.063 g/mL) fractions...


Source: Women's Health Weekly (1998-09-28)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login